The FDA has granted Israel-based Check-Cap conditional investigational device exemption approval for a pilot study of the C-Scan system, a capsule-based screening method that spots precancerous polyps to prevent colorectal cancer. The single-arm study aims to assess the safety, subject compliance and usability of the system in patients who have an average risk of colon cancer and polyps.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.